There were 1,758 press releases posted in the last 24 hours and 400,303 in the last 365 days.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CSVI, AERI, RCKT, RCOR

NEW YORK, Oct. 16, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Computer Services, Inc. CSVI's sale to Centerbridge Partners, L.P. and Bridgeport Partners for $58.00 per share. If you are a Computer Services shareholder, click here to learn more about your rights and options.

Aerie Pharmaceuticals, Inc. AERI's sale to Alcon for $15.25 per share. If you are an Aerie shareholder, click here to learn more about your rights and options.

Rocket Pharmaceuticals, Inc. RCKT's merger with Renovacor, Inc. If you are a Rocket shareholder, click here to learn more about your rights and options.

Renovacor, Inc. RCOR's sale to Rocket Pharmaceuticals, Inc. for approximately 0.1676 shares of Rocket for each Renovacor share. Upon completion of the transaction, Renovacor shareholders are expected to own approximately 4.6% percent of Rocket. If you are a Renovacor Health shareholder, click here to learn more about your rights and options.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com  
https://www.halpersadeh.com


Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.